Showing all 33 results
Amlodipine & Enalapril Maleate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets to protect the Enalapril Maleate from moisture-induced degradation and to ensure the physical integrity of the combination.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker (CCB) Enalapril Maleate BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Sodium Stearyl Fumarate / Lactose Lubricant & Stabilizer Amlodipine Besylate & Losartan Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The formulation is optimized for 24-hour efficacy, allowing for convenient once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine Besylate BP/USP 5 mg Calcium Channel Blocker (CCB) Losartan Potassium BP/USP 50 mg Angiotensin Receptor Blocker (ARB) Excipients Q.S. Microcrystalline Cellulose / Starch Stabilizing Core Matrix Amlodipine Tablet
FreeAmlodipine Tablets IP 5 mg
Each Uncoated tablet contains :
Amlodipine Besylate IP
Eq to Amlodipine 5 mgAmlodipine Tablets IP 10 mg
Each Uncoated Tablet Contains :
Amlodipine Besylate IP
Eq To Amlodipine 10 mgAmlodipine Besylate Tablets IP 2.5 mg
Each uncoated tablet contains :
Amlodipine Besylate IP
Eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 2.5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 5 mgAMLODIPINE & ENALAPRIL MALEATE TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Enalapril Maleate 5 mg
Excipients q.sAMLODIPINE & LISINOPRIL TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Lisinopril dihydrate
Eq. To Lisinopril 5 mg
Excipients q.sTRIPPLEACE AMLODIPINE -10 / AMLODIPINE
TABLETS 10 MG
Each uncoated tablet contains:
Amlodipine Besilate BP
Equivalent to Amlodipine 10 mg
Excipients Q.S.Usage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – hypertensive, Cardiovascular Agent,
Amlodipine With Lisinopril Dehydrate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The use of Lisinopril in its Dihydrate form ensures superior stability and predictable dissolution profiles.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker Lisinopril (as Dihydrate) BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Calcium Phosphate / Mannitol Stabilizing Agents Atenolol & Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The combination is engineered to maintain therapeutic plasma levels over a 24-hour period, supporting once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Atenolol BP/USP 50 mg / 100 mg Cardioselective Beta-Blocker Chlorthalidone BP/USP 12.5 mg / 25 mg Long-acting Diuretic Excipients Q.S. Magnesium Stearate / Povidone Stabilizing Core Matrix Atenolol Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets (often scored for dosage adjustment).
Active Ingredient Strength (Standard) Role Atenolol IP/BP/USP 25 mg Low Dose / Renal Impairment Atenolol IP/BP/USP 50 mg Standard Adult Dose Atenolol IP/BP/USP 100 mg High Potency / Angina Excipients Q.S. Binder / Disintegrant Bisoprolol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (distinctively shaped/scored). The low-dose range is critical for the “Start Low, Go Slow” titration required in heart failure.
Active Ingredient Strength (Standard) Shape/Color Primary Role Bisoprolol Fumarate USP/BP 2.5 mg White (Scored) Heart Failure Initiation Bisoprolol Fumarate USP/BP 5 mg Yellow/Pink (Scored) Standard Hypertension Bisoprolol Fumarate USP/BP 10 mg Orange/White High Dose Maintenance Excipients Q.S. Microcrystalline Cellulose / Hypromellose Filler / Coating Candesartan Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored). The wide range of strengths allows for precise titration in heart failure patients.
Active Ingredient Strength (Standard) Primary Role Candesartan Cilexetil USP/BP 4 mg Heart Failure Initiation / Hepatic Impairment Candesartan Cilexetil USP/BP 8 mg Standard Hypertension Start Candesartan Cilexetil USP/BP 16 mg Standard Maintenance Candesartan Cilexetil USP/BP 32 mg High Dose / Resistant Hypertension Carvedilol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Because therapy for Heart Failure requires very precise “low dose” initiation, we offer the full titration range.
Active Ingredient Strength (Standard) Color Code (Typical) Role Carvedilol USP/BP 3.125 mg White/Pink CHF Initiation (Critical) Carvedilol USP/BP 6.25 mg Yellow Titration Step 1 Carvedilol USP/BP 12.5 mg Tan/Peach Titration Step 2 Carvedilol USP/BP 25 mg White Target Maintenance Dose Clonidine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Small, White). Note: Clonidine is extremely potent and dosed in micrograms (mcg), not milligrams.
Active Ingredient Strength (Metric) Strength (Common) Primary Role Clonidine HCl USP/BP/IP 100 mcg 0.1 mg Initiation / Mild Hypertension Clonidine HCl USP/BP/IP 200 mcg 0.2 mg Standard Maintenance Clonidine HCl USP/BP/IP 300 mcg 0.3 mg High Dose / Crisis Management Excipients Q.S. Lactose / Corn Starch Filler / Binder Enalapril Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for titration). The wide range of strengths allows for the “Start Low, Go Slow” dosing strategy essential for heart failure.
Active Ingredient Strength (Standard) Primary Role Enalapril Maleate USP/BP 2.5 mg Heart Failure Initiation Enalapril Maleate USP/BP 5 mg Hypertension Initiation Enalapril Maleate USP/BP 10 mg Maintenance Dose Enalapril Maleate USP/BP 20 mg High Strength Hydralazine Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated or Film Coated Tablets (often Yellow or Orange). Uncoated tablets are avoided due to stability issues.
Active Ingredient Strength (Standard) Role Hydralazine HCl USP/BP 25 mg Initial Dose / Titration Hydralazine HCl USP/BP 50 mg Maintenance Dose Excipients Q.S. Coating Agents / Stabilizers Imidapril Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for precise titration). The standard strengths are optimized for maintenance therapy.
Active Ingredient Strength (Standard) Role Imidapril HCl 5 mg Initial Dose / Renal Impairment Imidapril HCl 10 mg Standard Maintenance Dose Excipients Q.S. Lactose / Macrogol Indapamide Tablets
FreeProduct Composition & Strength
We supply this product as Sugar/Film Coated Tablets (Immediate Release) or Sustained Release (SR) Tablets.
Active Ingredient Strength Formulation Role Indapamide USP/BP 1.5 mg Sustained Release (SR) Modern Standard Dose (24hr Control) Indapamide USP/BP 2.5 mg Immediate Release Classic Maintenance Dose Excipients Q.S. HPMC (Matrix) / Lactose Release Control Lisinopril Tablet
FreeProduct Composition & Available Portfolio Range
We manufacture Lisinopril in exact, compendial strengths calibrated to support initial introductory titration up to high-potency cardioprotective maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lisinopril Anhydrous / Dihydrate USP / BP / IP 5 mg Oral Solid Uncoated Tablet Initial Titration: For low-dose introductory management, pediatric hypertension, or initial combination therapy initiation. Lisinopril Anhydrous / Dihydrate USP / BP / IP 10 mg Oral Solid Uncoated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Lisinopril Anhydrous / Dihydrate USP / BP / IP 20 mg Oral High-Potency Solid Tablet Advanced Cardioprotection: High-strength configuration calibrated for severe heart failure management and post-infarction survival optimization. Losartan Potassium Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically Yellow or White, Oval). The coating protects the hygroscopic Losartan from moisture.
Active Ingredient Strength (Standard) Therapeutic Role Losartan Potassium USP/BP 50 mg Vasodilator (ARB) Hydrochlorothiazide USP/BP 12.5 mg Diuretic (Thiazide) (High Strength Variant) 100 mg Losartan + 25 mg HCTZ Severe Hypertension Excipients Q.S. Microcrystalline Cellulose / Lactose / Magnesium Stearate Filler / Lubricant Losartan Potassium, Amlodipine Besylate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically White or Yellow, Oval/Round). The formulation uses the Besylate salt of Amlodipine for maximum stability.
Active Ingredient Strength (Standard) Therapeutic Role Losartan Potassium USP/BP 50 mg Vasodilator (ARB) Amlodipine Besylate USP/BP 5 mg (Eq. to Base) Vasodilator (CCB) (High Strength Variant) 50 mg Losartan + 10 mg Amlodipine
100 mg Losartan + 5 mg AmlodipineResistant Hypertension Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate Filler / Super-Disintegrant Losartan Tablet
FreeProduct Composition & Available Strengths
We supply Losartan Potassium across the complete, internationally recognized therapeutic range to facilitate progressive dose titrations and precise maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Losartan Potassium USP / BP / IP 25 mg Oral Solid Film-Coated Tablet Pediatric & Low-Dose Titration: For introductory pediatric hypertension care or initial combination-therapy building. Losartan Potassium USP / BP / IP 50 mg Oral Solid Film-Coated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Losartan Potassium USP / BP / IP 100 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: For advanced hypertensive management, diabetic nephropathy progression delay, and stroke risk reduction in left ventricular hypertrophy. Methyldopa Tablet
FreeProduct Composition & Available Strengths
We supply Methyldopa in standard, exact strengths designed to facilitate the careful, progressive dose titration required in gestational healthcare.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Methyldopa Anhydrous IP / BP / USP 250 mg Oral Solid Film-Coated Tablet (Scored for micro-titration) Initial Titration / Baseline Care: For early-stage gestational hypertension and lower-dose fine-tuning. Methyldopa Anhydrous IP / BP / USP 500 mg Oral Solid Film-Coated Tablet (Engineered for uniform mass release) High-Potency Maintenance: For advanced chronic hypertension during pregnancy and severe pre-eclamptic stabilization. Metoprolol & Amlodipin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined molecules.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Tartrate/Succinate ER) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac workload, and neutralizes CCB-induced reflex tachycardia. Amlodipine (as Besylate) Ph.Eur./USP 5 mg Calcium Channel Blocker (CCB): Forces profound peripheral arterial vasodilation, dropping severe blood pressure and relieving coronary spasms. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Crospovidone / Magnesium Stearate / Premium Opadry Film / Iron Oxide Colors Diluent / Stabilizing Buffer / Superdisintegrant / Lubricant (Engineered specifically using bilayer press technology to physically separate the slightly acidic Metoprolol salt from the basic Amlodipine, preventing destructive chemical cross-talk) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Metoprolol & Ramipril Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Succinate/Tartrate) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac output, and myocardial oxygen demand; protects against sudden cardiac death. Ramipril Ph.Eur./USP 2.5 mg / 5 mg ACE Inhibitor Driver: Forces profound systemic vasodilation, protects the kidneys (renoprotection), and halts pathological cardiac remodeling. Excipients Microcrystalline Cellulose / Sodium Stearyl Fumarate / Hypromellose / Sodium Bicarbonate / Iron Oxide Colors Low-Moisture Diluent / Lubricant / Film-Coating / Polymeric Stabilizer (Engineered specifically to physically isolate the acidic Ramipril from cross-reacting with the Metoprolol salt, preventing the formation of toxic diketopiperazine impurities) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol & Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic and pH-sensitive active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Nitric Oxide Donating Beta-Blocker: Reduces cardiac workload while promoting active peripheral vasodilation and preserving sexual function. Telmisartan Ph.Eur./USP 40 mg Metabolic ARB: Provides sustained 24-hour RAAS blockade and improves cellular insulin sensitivity (PPAR-γ modulation). Excipients Meglumine / Sodium Hydroxide / Microcrystalline Cellulose / Povidone K30 / Polysorbate 80 / Magnesium Stearate Alkalizing Agents (Meglumine) / Diluent / Binder / Surfactant (Engineered specifically to create a hyper-alkaline micro-environment for Telmisartan dissolution, physically isolated from the Nebivolol layer to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 5 mg Cardioselective & Vasodilatory Base: Reduces cardiac workload and provides active Nitric Oxide-driven peripheral vasodilation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Thiazide Diuretic Driver: Forces the excretion of excess sodium and water, massively amplifying the blood-pressure-lowering effect of the beta-blocker. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Polysorbate 80 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Wetting Surfactant / Moisture-Barrier Coating (Engineered specifically to protect the highly delicate racemic Nebivolol balance while ensuring rapid, synchronized gastric dissolution of the diuretic) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Global Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension. Nebivolol (as HCl) Ph.Eur./USP 10 mg / 20 mg Advanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).
Nifedipine Tablet
FreeProduct Composition & Structural Formats
We manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
Active Ingredient Available Strengths Formulation Matrix Delivery System Primary Clinical Focus Nifedipine IP/BP/USP 10 mg Immediate-Release / Rapid-Onset Film Tablet Acute Titration / Tocolysis: For severe acute hypertension or suppression of premature labor contractions. Nifedipine IP/BP/USP 20 mg Sustained-Release (SR) Retard Matrix Twice-Daily Maintenance: Intermediate control for stable chronic hypertension. Nifedipine IP/BP/USP 30 mg Once-Daily Extended-Release (XR / XL) Matrix First-Line Chronic Care: Continuous 24-hour plasma stabilization for mild-to-moderate hypertension. Nifedipine IP/BP/USP 60 mg Once-Daily Extended-Release (XR / XL) Matrix High-Potency Control: For refractory essential hypertension and severe chronic stable angina pectoris. Nifedipine Tablet
FreeProduct Composition & Structural Formats
We supply Nifedipine in exact, internationally standardized strengths, optimized for immediate-release emergency titration or controlled-release daily maintenance.
Active Ingredient Available Strengths Formulation Mechanism Primary Clinical Target Nifedipine IP / BP / USP 10 mg Immediate or Modified Release Acute Titration / Tocolysis: For rapid blood pressure adjustment or suppression of premature labor. Nifedipine IP / BP / USP 20 mg Sustained / Retard Matrix Daily Maintenance: Continuous 12-to-24-hour plasma concentration for chronic hypertension and angina. Olmesartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile ester prodrug.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg Initiation / Global Standard: Standard adult starting and maintenance dose for the continuous control of essential hypertension. Olmesartan Medoxomil Ph.Eur./USP 40 mg Severe Refractory Standard: Maximum adult maintenance dose for patients requiring further reduction in blood pressure. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Hydroxypropyl Cellulose / Magnesium Stearate / Titanium Dioxide Low-Moisture Diluent / Binder / Lubricant / Premium Moisture-Barrier Film-Coating (Engineered specifically to lock out ambient humidity and prevent the premature hydrolysis of the medoxomil group prior to ingestion) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Prazosin Tablets
FreePrazosin Tablets IP 2 mg
Each filmcoated tablet contains:
Prazosin Hydrochloride IP
Eq to Prazosin 2 mgPRAZOSIN TABLETS IP 2.5 MG Each film coated Tablet Contains:
Prazosin hydrochloride IP equivalent to prazosin 2.5 mg Excipients q.s.PRAZOSIN TABLETS IP 5 MG Each film coated Tablet Contains:
Prazosin hydrochloride IP equivalent to prazosin 5 mg Excipients q.s.Usage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Ramipril & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg (or 2.5 mg / 10 mg) ACE inhibition for vasodilation, RAAS blockade, and critical potassium retention. Hydrochlorothiazide Ph.Eur./USP 12.5 mg / 25 mg Global Clinical Standard: Thiazide diuretic for sodium excretion and sustained blood volume reduction. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Bicarbonate / Hypromellose / Magnesium Stearate Diluent / Superdisintegrant / Alkaline Stabilizing Agent (Engineered specifically to protect Ramipril from acidic degradation and moisture-induced cyclization) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Ramipril Tablets
FreeRamipril Tablets IP 2.5mg
Each Film coated tablet contains:
Ramipril IP 2.5 mgRamipril tablets IP 5 mg
Each Filmcoated tablet contains :
Ramipril IP 5 mgUsage: – high blood pressure and heart failure
Category: – Anti Cardiovascular drugs
Therapeutic category: – Cardiovascular Agent, Antihypertensive
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Telmisartan & Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Bilayer or Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the micro-dosed diuretic.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Standard ARB maintenance dose for continuous 24-hour peripheral vasodilation and RAAS blockade. Chlorthalidone USP/Ph.Eur. 6.25 mg Highly precise, long-acting thiazide-like diuresis optimized for maximum safety and efficacy. Excipients Meglumine / Sodium Hydroxide / Microcrystalline Cellulose / Sodium Starch Glycolate Alkalizer for Telmisartan / Diluent / Superdisintegrant (Engineered for kinetic segregation and immediate dissolution) Telmisartan Tablets
FreeTELMIZIDE TABLETS
Telmisartan With Hydrochlorthiazide Tablet
Each Film Coated Tablet contains:
Telmisartan 40 mg
Hydrochlorthiazide IP 12.5 mgUsage: – treat high blood pressure (hypertension)
Category: – Anti Cardiovascular drugs
Therapeutic category: – Cardiovascular Agent, Antihypertensive
Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips. The formulation utilizes specialized alkalizing agents to ensure the highly insoluble API rapidly dissolves in the gastrointestinal tract.
Active Ingredient Strength Primary Clinical Use Telmisartan USP/BP/Ph.Eur. 20 mg Initiation / Hepatic Impairment: Low-dose titration for sensitive or hepatically compromised patients. Telmisartan USP/BP/Ph.Eur. 40 mg Standard Global Dose: Once-daily maintenance therapy for essential hypertension. Telmisartan USP/BP/Ph.Eur. 80 mg Maximum CV Protection: High-dose therapy for severe hypertension and mandated cardiovascular risk reduction. Excipients Meglumine / Sodium Hydroxide / Povidone / Magnesium Stearate Alkalizing Stabilizer / Binder / Lubricant (Engineered to prevent API crystallization and ensure rapid absorption)
